Back to Search
Start Over
Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1
- Source :
- Clinical Case Reports, Vol 8, Iss 11, Pp 2125-2128 (2020)
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Abstract Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c‐NFs) and promote growth of pre‐existing c‐NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 8
- Issue :
- 11
- Database :
- Directory of Open Access Journals
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7c7980e28a9c45b79e6b97b82fb9b441
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/ccr3.3071